CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Medivation Prostate Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
Aug 18, 2021Formulations Of Enzalutamide11
Aug 22, 2018Treatment Of Breast Cancer1

Top competitors of Medivation Prostate Therapeutics

Top competitors of Medivation Prostate Therapeutics based on patent oppositions.